Skip to content

Regenxbio RGNX Increase Decrease In Operating Lease Liabilities

Increase Decrease In Operating Lease Liabilities at other companies

Intellia Therapeutics logo
Intellia TherapeuticsNTLA
-$12.84M+55.8%
Box logo
BoxBOX
$6.67M+6.0%
SkyWest logo
SkyWestSKYW
$1.45M+676%
Matsons logo
MatsonsMATX
-$29.8M+15.1%
Netscout Systems logo
Netscout SystemsNTCT
-$2.56M+13.0%
Trustco Bank Corp logo
Trustco Bank CorpTRST
-$1.78M+2.8%

Other financials

Income statement

See full
Revenue$6.4M-92.8%
Gross profit$14.9M+35.7%
Operating income-$83.4M-787%
Net income-$90.1M-1,580%
EPS (diluted)-$1.72-1,533%

Balance sheet

See full
Cash & equivalents$15.2M-88.3%
Total debt$71.1M-11.0%
Total equity$21.1M-92.3%
Total assets$341.9M-30.4%

Cash flow

See full
Operating cash flow-$76.2M-327%
CapEx$1.2M+20.6%
Free cash flow-$77.4M-337%

Valuation

See full
Market cap$529.38M+24.6%
Enterprise value$585.22M+56.3%
P/S+3.3×

Profitability

See full
Gross margin59.7%+1.0pp
Operating margin-292.3%-613pp
Net margin-330.2%-588pp
FCF margin-269.2%-364pp

Returns & leverage

See full
Return on equity-196.4%-288pp
Debt / equity3.4×+3.1×
Current ratio2.6×-0.3×

Where this comes from

Reported directly by Regenxbio in its filing.

Tagged under the XBRL concept rgnx:IncreaseDecreaseInOperatingLeaseLiabilities.

The official record: Regenxbio’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regenxbio's increase decrease in operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Regenxbio's increase decrease in operating lease liabilities?
Regenxbio (RGNX) reported increase decrease in operating lease liabilities of -$2.53M in Q1 2026.
How has Regenxbio's increase decrease in operating lease liabilities changed year-over-year?
Regenxbio's increase decrease in operating lease liabilities decreased by 13.8% year-over-year, from -$2.22M to -$2.53M.
What is the long-term trend for Regenxbio's increase decrease in operating lease liabilities?
Over 4 years (2021 to 2025), Regenxbio's increase decrease in operating lease liabilities has grown at a -8.1% compound annual growth rate (CAGR), from $12.07M to -$8.63M.
What does increase decrease in operating lease liabilities mean?
This reflects the change in the present value of future lease payments, excluding the portion attributed to interest. It captures the reduction of lease obligations through cash payments and adjustments for new or modified leases. This metric is critical for evaluating the company's long-term fixed obligations and its overall leverage profile.